These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32054986)

  • 21. Arctigenin suppresses transforming growth factor-β1-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial-mesenchymal transition through reactive oxygen species-dependent ERK/NF-κB signaling pathway in renal tubular epithelial cells.
    Li A; Wang J; Zhu D; Zhang X; Pan R; Wang R
    Free Radic Res; 2015; 49(9):1095-113. PubMed ID: 25968940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells.
    Liu Y; Bi X; Xiong J; Han W; Xiao T; Xu X; Yang K; Liu C; Jiang W; He T; Yu Y; Li Y; Zhang J; Zhang B; Zhao J
    Mol Ther; 2019 May; 27(5):1051-1065. PubMed ID: 30853453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schisandrin B Alleviates Renal Tubular Cell Epithelial-Mesenchymal Transition and Mitochondrial Dysfunction by Kielin/Chordin-like Protein Upregulation via Akt Pathway Inactivation and Adenosine 5'-Monophosphate (AMP)-Activated Protein Kinase Pathway Activation in Diabetic Kidney Disease.
    Liu W; Li F; Guo D; Du C; Zhao S; Li J; Yan Z; Hao J
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells.
    Zhu Z; Luan G; Peng S; Fang Y; Fang Q; Shen S; Wu K; Qian S; Jia W; Ye J; Wei L
    Phytomedicine; 2023 Oct; 119():154975. PubMed ID: 37517171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease.
    Burns WC; Twigg SM; Forbes JM; Pete J; Tikellis C; Thallas-Bonke V; Thomas MC; Cooper ME; Kantharidis P
    J Am Soc Nephrol; 2006 Sep; 17(9):2484-94. PubMed ID: 16914537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease.
    Liu YN; Zhou J; Li T; Wu J; Xie SH; Liu HF; Liu Z; Park TS; Wang Y; Liu WJ
    J Diabetes Res; 2017; 2017():4989847. PubMed ID: 28929120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
    Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
    Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trigonelline inhibits tubular epithelial-mesenchymal transformation in diabetic kidney disease via targeting Smad7.
    Gong M; Guo Y; Dong H; Wu W; Wu F; Lu F
    Biomed Pharmacother; 2023 Dec; 168():115747. PubMed ID: 37864898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Klotho mitigates cyclosporine A (CsA)-induced epithelial-mesenchymal transition (EMT) and renal fibrosis in rats.
    Liu QF; Ye JM; Yu LX; Dong XH; Feng JH; Xiong Y; Gu XX; Li SS
    Int Urol Nephrol; 2017 Feb; 49(2):345-352. PubMed ID: 27796696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.
    Hu Y; Tang W; Liu W; Hu Z; Pan C
    Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
    Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non‑coding RNA NEAT1 promotes pulmonary fibrosis by regulating the microRNA‑455‑3p/SMAD3 axis.
    Liu Y; Lu FA; Wang L; Wang YF; Wu CF
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
    Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
    Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
    Kang MK; Park SH; Choi YJ; Shin D; Kang YH
    J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitor of growth 2 regulates the high glucose-induced cell cycle arrest and epithelial-to-mesenchymal transition in renal proximal tubular cells.
    Ma Y; Yan R; Wan Q; Lv B; Yang Y; Lv T; Xin W
    J Physiol Biochem; 2020 Aug; 76(3):373-382. PubMed ID: 32424454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
    Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C
    Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
    Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
    Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micro-vesicles from mesenchymal stem cells over-expressing miR-34a inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition in renal tubular epithelial cells in vitro.
    He J; Jiang YL; Wang Y; Tian XJ; Sun SR
    Chin Med J (Engl); 2020 Apr; 133(7):800-807. PubMed ID: 32149762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy.
    Oh HJ; Nam BY; Wu M; Kim S; Park J; Kang S; Park JT; Yoo TH; Kang SW; Han SH
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F791-F805. PubMed ID: 29638159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.